PT - JOURNAL ARTICLE AU - Ildar I Sadreev AU - Benjamin L Elsworth AU - Ruth E Mitchell AU - Lavinia Paternoster AU - Eleanor Sanderson AU - Neil M Davies AU - Louise AC Millard AU - George Davey Smith AU - Philip C Haycock AU - Jack Bowden AU - Tom R Gaunt AU - Gibran Hemani TI - Navigating sample overlap, winner’s curse and weak instrument bias in Mendelian randomization studies using the UK Biobank AID - 10.1101/2021.06.28.21259622 DP - 2021 Jan 01 TA - medRxiv PG - 2021.06.28.21259622 4099 - http://medrxiv.org/content/early/2021/07/01/2021.06.28.21259622.short 4100 - http://medrxiv.org/content/early/2021/07/01/2021.06.28.21259622.full AB - We performed GWAS on 2514 complex traits from the UK Biobank using a linear mixed model, identifying 40,620 independent significant associations (p<5×10−8). We estimate that winner’s curse incurs substantial overestimation of effect sizes in a mean of 35% of discovered associations per trait. We use these results to estimate that the polygenicity of most complex traits is below 10000 common causal variants. We evaluated the impact of winner’s curse on causal effect estimation and hypothesis testing in Mendelian randomization analyses. We show that winner’s curse substantially amplifies the magnitude of weak instrument bias, though any inflation of false discovery rates tends to be low or modest. We designed a process of pseudo-replication within the UK Biobank data to generate GWAS estimates that minimise bias in MR studies using these data. Our resource is integrated into the OpenGWAS platform and enables a convenient framework for researchers to minimise bias or maximise precision of causal effect estimates.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded in part by the Wellcome Trust and the Royal Society [208806/Z/17/Z] and the UK Medical Research Council (MRC Integrative Epidemiology Unit MC_UU_00011/1 and MC_UU_00011/4). NMD is supported by a Norwegian Research Council Grant number 295989. JB is supported by an Expanding Excellence in England (E3) research grant awarded to the University of Exeter. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe GWAS summary data generated as part of this study are available in the OpenGWAS database under batch IDs ukb-b, ukb-ba, ukb-bb at https://gwas.mrcieu.ac.uk/. Code used to generate the GWAS summary data is available here: https://github.com/MRCIEU/BiobankGWAS/ Code used for the other statistical analysis in the study is available here: https://github.com/isadreev/UKBB_replication https://gwas.mrcieu.ac.uk/